התחייבויות לטווח ארוך: Pacific Biosciences of California, Inc. (PACB)

The current market quotes for Pacific Biosciences (PACB), a company specializing in the development of DNA analysis tools, as visualized below on GURU.Markets, show debt at the level of 0.00. Steady cash flow is driven by consistent demand for equipment and consumables. The high precision of Revio systems ensures pricing power, while the application of these technologies in the agricultural and medical sectors significantly expands the company's market presence.

Scaling Revio systems and the expansion of HiFi sequencing require significant capital expenditures in infrastructure. Analyzing the state of the organization's long-term financial debt, the investor assesses the total volume of credit obligations with a maturity of more than one year. The dynamics of this indicator determine the level of debt load and the risk of default when forming regular cash flows. The stability of this metric confirms the resilience of the Pacific Biosciences (PACB) business model in the eyes of the market.